Delivery Order SPE2DR25D1100-SPE2DR26FCK9F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging (30-count) with a ceiling value of $2,705.69. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adzenys XR-ODT 3.1 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,063.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement awarded through competitive bidding. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,504.87 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adzenys XR-ODT 9.4 mg tablets in unit-dose packaging (30 tablets). This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $2,246.98 and represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.67 to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 12.5 mg tablets (30-count unit dose packages) with a completion date of September 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging of 30 units, with a ceiling value of $1,927.41. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This delivery order, awarded on October 27, 2025, to AmerisourceBergen Drug Corp represents a $1,612.12 firm fixed-price purchase of ADZENYS XR ODT Tablets (6.3 mg) for the Defense Logistics Agency's Medical Supply Chain. The award is non-competitive and is expected to be completed by October 28, 2025. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order valued at $4,143.14 to AmerisourceBergen Drug Corp for ADZENYS XR-ODT 18.8 mg tablets (30-count unit dose packages) on October 21, 2025, with completion scheduled for October 22, 2025. This firm fixed price contract was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCK9FDelivery Order
The Defense Logistics Agency awarded a $2,494.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adzenys XR-ODT 15.7 mg tablets (30-count unit dose packaging). The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply agreement through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Adzenys XR-ODT product is an extended-release orally disintegrating tablet formulation used for attention-deficit/hyperactivity disorder treatment, consistent with the company's extensive portfolio of neurological and specialty medications delivered through the DLA Medical Supply Chain. This delivery order represents a routine transactional award under the broader IDC framework, demonstrating the contractor's continued capability to fulfill federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/28/25 |